The FLOWSCRIPT® Assay employs a novel, flow cytometry-based, in situ hybridization technique to ensure the detection of mRNA transcripts associated with the most prevalent high-risk HPV genotypes.
Enzo’s innovations are changing the story of HPV. The FLOWSCRIPT® Assay employs a novel, flow cytometry-based, in situ hybridization technique, utilizing a cocktail of probes specific to multiple sites within the E6 and E7 mRNA, to ensure the detection of mRNA transcripts associated with the most prevalent high-risk HPV genotypes. To learn more about Enzo’s latest addition to its suite of HPV-detection products, the FLOWSCRIPT® HPV E6/E7 Assay, visit the Enzo website.
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
